Overexpression of fragile X gene (FMR-1) transcripts increases camp production in neural cells

Journal of Neuroscience Research

Volumn 51, Issue 1, 1998, Pages 41-48

  Berry Kravis, Elizabeth ^a   Ciurlionis, Rita ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cAMP; FMRP; Fragile X syndrome; Gene transfection; Signal transduction

Indexed keywords

CYCLIC AMP; TRINUCLEOTIDE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; FRAGILE X SYNDROME; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRINUCLEOTIDE REPEAT;

ANIMALS; CELLS, CULTURED; CYCLIC AMP; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; MICE; NEURONS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031930176     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L     Document Type: Article

References (40)

1. Ashley CT, Sutcliffe JS, Kunst CB, Leiner HA, Eichler EE, Nelson DL, Warren ST (1993a): Human and murine FMR-1: Alternative splicing and translation initiation downstream of the CGG-repeat. Nat Genet 4:244-251.
2. Ashley CT, Wilkinson KD, Reines D, Warren ST (1993b): FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262:563-566.
3. Banerjee P, Berry-Kravis E, Bonafede-Chhabra D, Dawson G (1993): Heterologous expression of the 5HT1a receptor in neural and non-neural cell lines. Biochem Biophys Res Commun 192:104-110.
4. Banerjee P, Chromy BA, Berry-Kravis E, Hammond D, Singh JK, Dawson G (1996): Stable expression and heterologous coupling of the kappa opioid receptor in cell lines of neural and non-neural origin. Life Sci 58:1277-1284.
5. Berry-Kravis E, Dawson G (1983): Characterization of an adenylate cyclase-linked serotonin (5HT1) receptor in a neuroblastoma × brain explant hybrid cell line (NCB-20). J Neurochem 40:977-985.
6. Berry-Kravis E, Huttenlocher P (1992): Cyclic AMP metabolism in fragile X syndrome. Ann Neurol 31:22-26.
7. Berry-Kravis E, Sklena P (1992): Demonstration of abnormal cAMP production in platelets from patients with fragile X syndrome. Am J Med Genet 45:81-87.
8. Berry-Kravis E, Hicar M, Ciurlionis R (1995): Reduced cyclic AMP production in fragile X syndrome: Cytogenetic and molecular correlations. Pediatr Res 38:638-643.
9. Brook JD, McCurrach ME, Harley HG, Buckler HJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion J-P, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shew DJ, Housman DE (1992): Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808.
10. Brooker G, Harper JF, Terasaki WL, Moylan RD (1979): Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10:1-33.
11. Brown WT (1990): The fragile X: Progress towards solving the puzzle. Am J Hum Genet 47:175-180.
12. Connolly JB, Roberts IJH, Armstrong JD, Kaiser K, Forte M, Tully T, O'Kane CJ (1996): Associative learning disrupted by impaired Gs signaling in Drosophila mushroom bodies. Science 274:2104-2107.
13. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L (1993): The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
14. Dudai Y (1986): Cyclic AMP and learning in Drosophila. Adv Cyclic Nucleotide Prot Phos Res 20:343-361.
15. Dutch-Belgian Fragile X Consortium (1994): FMR1 knockout mice: A model to study fragile X mental retardation. Cell 78:23-33.
16. Farfel Z, Friedman E (1986): Mental deficiency in pseudohypoparathyroidism type I is associated with N-protein deficiency. Ann Intern Med 105:197-199.
17. Feng Y, Gutekunst C-A, Eberhart DE, Yi H, Warren ST, Hersch SM (1997): Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.
18. Freund LS, Reiss AL (1992): Cognitive profiles associated with the fra(X) syndrome in males and females. Am J Med Genet 38:542-547.
19. Hagerman RJ (1991): Physical and behavioral phenotype. In Hagerman RJ, Silverman AC (eds): "Fragile X Syndrome: Diagnosis, Treatment and Research. "Baltimore: Johns Hopkins University Press, pp 3-68.
20. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O'Connor RA, Seydel C, Mazzocco MM, Snow K, Thibodeau SN, Kuhl D, Nelson DL, Caskey CT, Taylor A (1994): High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51:298-308.
21. Iyengar R (1993): Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J 7:768-775.
22. Kandel E, Abel T (1995): Neuropeptides, adenylyl cyclase, and memory storage. Science 268:825-826.
23. Kandel ER, Schwartz JH (1982): Molecular biology of learning: Modulation of transmitter release. Science 218:433-443.
24. Kang H, Schuman EM (1996): A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273:1402-1406.
25. Khandjian EW, Corbin F, Woerly S, Rousseau F (1996): The fragile X mental retardation protein is associated with ribosomes. Nat Genet 12:91-93.
26. Krupinski J, Lehman TC, Frankenfield CD, Zwaagstra JC, Watson PA (1992): Molecular diversity in the adenylyl cyclase family: Evidence for eight forms of the enzyme and cloning of type VI. J Biol Chem 267:24858-24862.
27. Lee HJ, Hammond DN, Large TH, Roback JD, Sim JA, Brown DA, Otten UH, Wainer BH (1990): Neuronal properties and trophicactivities of immortalized hippocampal cells from embryonic and young adult mice. J Neurosci 10:1779-1787.
28. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ (1951): Protein measurement with the folin reagent. J Biol Chem 193:265-275.
29. Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Nelson DL, Caskey CT (1991): Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
30. Reiss AL, Freund L (1990): Fragile X syndrome. Biol Psychiatry 27:223-240.
31. Silva AJ, Paylor R, Wehner JM, Tonegawa S (1992): Impaired spatial learning in α-calcium-calmodulin kinase II mutant mice. Science 257:206-211.
32. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G (1994): Essential role for KH domains in RNA binding: Impaired RNA binding by a point mutation in the KH domain of FMRI that causes fragile X syndrome. Cell 77:33-39.
33. Sittler A, Devys D, Weber C, Mandel J-L (1996): Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of FMRI protein isoforms. Hum Mol Genet 5:95-102.
34. Tamanini F, Meijer N, Verheij C, Willems PJ, Galjaard H, Oostra BA, Hoogeveen AT (1996): FMRP is associated to the ribosomes via RNA. Hum Mol Genet 5:809-813.
35. Verheij C, Bakker CE, de-Graff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, Reuser AJ, Hoogeveen AT, Oostra BA (1993): Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
36. Verheij C, De Graff E, Bakker CE, Willemson R, Willems PJ, Meijer N, Galjaard H, Reuser AJJ, Oostra BA, Hoogeveen AT (1995): Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet 4:895-901.
37. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Vicoria MF, Zhang F, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991): Identification of a gene (FMR-1) containing a CGG repeat co-incident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
38. Weiler IJ, Hawrylak N, Greenough WT (1995): Morphogenesis in memory formation: Synaptic and cellular mechanisms. Behav Brain Res 66:1-6.
39. Willemsen R, Bontekoe C, Tamanini F, Galjaard H, Hoogeveen A, Oostra B (1996): Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem Biophys Res Commun 225:27-33.
40. Wisniewski KE, Segan SM, Miezejeski CM, Sersen SM, Rudelli RD (1991): The fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 38:476-480.